Summary
Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Anastero is 2.8% (moderate). The 2024 annual accounts show equity of €149k and a net result of €34k. The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
Based on the State Gazette, CBE and 2 annual accounts.
Trust signals
3 signalsAdministrative Flags
0 eventsBankruptcy probability (12 mo)
Checked model v1 · free for everyoneStatistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Financials
Annual accounts & ratios
Source: NBB · 2024| Fiscal year | 2024 |
|---|---|
| Revenue | - |
| EBITDA | €57k |
| Net profit | €34k |
| Cash flow | €44k |
| Staff costs | €839 |
| Income taxes | €13k |
| Dividends | - |
| Total assets | €221k |
| Equity | €149k |
| Debt | €72k |
| of which ≤ 1y | €54k |
| of which > 1y | €18k |
| Working capital | €132k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 3.45 |
| Quick ratio | 3.45 |
| Working capital ratio | 59.8% |
| Solvency | 67.4% |
| Debt / equity | 0.48 |
| Long-term debt ratio | 0.12 |
| Interest coverage | 68.43 |
| Gross margin | - |
| Net margin | - |
| ROA | 15.5% |
| ROE | 23.0% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €221k |
| Fixed assets | 21/28 | €35k |
| Tangible fixed assets | 22/27 | €35k |
| Current assets | 29/58 | €186k |
| Amounts receivable within one year | 40/41 | €0 |
| Cash & bank | 54/58 | €178k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €221k |
| Equity | 10/15 | €149k |
| Contributions / capital | 10/11 | €5k |
| Reserves | 13 | €144k |
| Amounts payable | 17/49 | €72k |
| Amounts payable after one year | 17 | €18k |
| Amounts payable within one year | 42/48 | €54k |
| Trade debts payable within one year | 44 | €450 |
| Income statement | ||
| Gross operating margin | 9900 | €61k |
| Operating result | 9901 | €48k |
| Financial charges | 65 | €836 |
| Result before taxes | 9903 | €47k |
| Income taxes | 67/77 | €13k |
| Net result for the period | 9904 | €34k |
| Result to be appropriated | 9905 | €34k |
Health barometer
FY 2024 · computedUnlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →Structure & network
Locations & real estate
Establishment units
1 locationReal-estate footprint
Source: CBE × cadastre · address linkingParcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12029B0296/00K000 | Flanders | 2,078 m² | 1 · 140 m² | 7.2 m · 2 fl. |
Analysis
Snowflake analysis
financial profile on 5 axesExceptional profile, strong across almost every axis.
Ask AI about this company
Checked AISoon: ask questions about this dossier, risks, curator, sector comparison, answered from the official data on this page.
AI due-diligence brief
Checked AIGenerate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
Credit advice
verdict per customer and amountCompany registry
Company registry (CBE)
Crossroads Bank| Legal nameNL | Anastero |